These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 30270086

  • 1. Health related quality of life in individuals at high risk for familial hypercholesterolemia undergoing genetic cascade screening in Brazil.
    Souto AC, Miname MH, Fukushima J, Jannes CE, Krieger JE, Hagger M, Pereira AC, Santos RD.
    Atherosclerosis; 2018 Oct; 277():464-469. PubMed ID: 30270086
    [Abstract] [Full Text] [Related]

  • 2. Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of families.
    Truong TH, Kim NT, Nguyen MNT, Pang J, Hooper AJ, Watts GF, Do DL.
    Atherosclerosis; 2018 Oct; 277():392-398. PubMed ID: 30270076
    [Abstract] [Full Text] [Related]

  • 3. Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review.
    Groselj U, Kovac J, Sustar U, Mlinaric M, Fras Z, Podkrajsek KT, Battelino T.
    Atherosclerosis; 2018 Oct; 277():383-391. PubMed ID: 30270075
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of clinical and laboratory parameters used in the identification of index cases for genetic screening of familial hypercholesterolemia in Brazil.
    Silva PRS, Jannes CE, Oliveira TGM, Miname MH, Rocha VZ, Chacra AP, Gurgel MHC, Montenegro RM, Rodrigues Sobrinho CRM, Bello Moreira AS, Assad MHV, Pinto MRC, Tada MT, Santos RD, Pereira AC, Krieger JE.
    Atherosclerosis; 2017 Aug; 263():257-262. PubMed ID: 28689098
    [Abstract] [Full Text] [Related]

  • 5. Latvian registry of familial hypercholesterolemia: The first report of three-year results.
    Latkovskis G, Saripo V, Gilis D, Nesterovics G, Upena-Roze A, Erglis A.
    Atherosclerosis; 2018 Oct; 277():347-354. PubMed ID: 30270070
    [Abstract] [Full Text] [Related]

  • 6. Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk.
    Lee S, Akioyamen LE, Aljenedil S, Rivière JB, Ruel I, Genest J.
    Eur J Prev Cardiol; 2019 Aug; 26(12):1262-1270. PubMed ID: 30755017
    [Abstract] [Full Text] [Related]

  • 7. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
    deGoma EM, Ahmad ZS, O'Brien EC, Kindt I, Shrader P, Newman CB, Pokharel Y, Baum SJ, Hemphill LC, Hudgins LC, Ahmed CD, Gidding SS, Duffy D, Neal W, Wilemon K, Roe MT, Rader DJ, Ballantyne CM, Linton MF, Duell PB, Shapiro MD, Moriarty PM, Knowles JW.
    Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
    [Abstract] [Full Text] [Related]

  • 8. Cascade screening for familial hypercholesterolemia: Practical consequences.
    Louter L, Defesche J, Roeters van Lennep J.
    Atheroscler Suppl; 2017 Nov; 30():77-85. PubMed ID: 29096865
    [Abstract] [Full Text] [Related]

  • 9. Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
    Rizos CV, Elisaf MS, Skoumas I, Tziomalos K, Kotsis V, Rallidis L, Garoufi A, Athyros VG, Skalidis E, Kolovou G, Koutagiar I, Papagianni M, Antza C, Katsiki N, Ganotakis E, Liberopoulos EN.
    Atherosclerosis; 2018 Oct; 277():308-313. PubMed ID: 30270064
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-Term Cardiovascular Risk in Heterozygous Familial Hypercholesterolemia Relatives Identified by Cascade Screening.
    Kjærgaard KA, Christiansen MK, Schmidt M, Olsen MS, Jensen HK.
    J Am Heart Assoc; 2017 Jun 26; 6(6):. PubMed ID: 28652386
    [Abstract] [Full Text] [Related]

  • 12. Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales.
    Haralambos K, Whatley SD, Edwards R, Gingell R, Townsend D, Ashfield-Watt P, Lansberg P, Datta DB, McDowell IF.
    Atherosclerosis; 2015 May 26; 240(1):190-6. PubMed ID: 25797312
    [Abstract] [Full Text] [Related]

  • 13. Lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients with familial hypercholesterolemia in Germany: The CaReHigh Registry.
    Schmidt N, Dressel A, Grammer TB, Gouni-Berthold I, Julius U, Kassner U, Klose G, König C, Koenig W, Otte B, Parhofer KG, Reinhard W, Schatz U, Schunkert H, Steinhagen-Thiessen E, Vogt A, Laufs U, März W.
    Atherosclerosis; 2018 Oct 26; 277():314-322. PubMed ID: 30270065
    [Abstract] [Full Text] [Related]

  • 14. Real-life LDL-C treatment goals achievement in patients with heterozygous familial hypercholesterolemia in the Czech Republic and Slovakia: Results of the PLANET registry.
    Vrablik M, Raslová K, Vohnout B, Blaha V, Satny M, Kyselak O, Vaclova M, Urbanek R, Maskova J, Soska V, Freiberger T.
    Atherosclerosis; 2018 Oct 26; 277():355-361. PubMed ID: 30270071
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mutational analysis of the LDLR gene in a cohort of Colombian families with familial hypercholesterolemia.
    López G, Bernal LM, Gelvez N, Gómez LF, Nova A, Sánchez AI, Tamayo ML.
    Atherosclerosis; 2018 Oct 26; 277():434-439. PubMed ID: 30270082
    [Abstract] [Full Text] [Related]

  • 17. Novel combined variants of LDLR and LDLRAP1 genes causing severe familial hypercholesterolemia.
    Alnouri F, Athar M, Al-Allaf FA, Abduljaleel Z, Taher MM, Bouazzaoui A, Al Ammari D, Karrar H, Albabtain M.
    Atherosclerosis; 2018 Oct 26; 277():425-433. PubMed ID: 30270081
    [Abstract] [Full Text] [Related]

  • 18. Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies.
    Nherera L, Marks D, Minhas R, Thorogood M, Humphries SE.
    Heart; 2011 Jul 26; 97(14):1175-81. PubMed ID: 21685482
    [Abstract] [Full Text] [Related]

  • 19. Enhanced identification of familial hypercholesterolemia using central laboratory algorithms.
    Ibrahim S, Nurmohamed NS, Nierman MC, de Goeij JN, Zuurbier L, van Rooij J, Schonck WAM, de Vries J, Hovingh GK, Reeskamp LF, Stroes ESG.
    Atherosclerosis; 2024 Jun 26; 393():117548. PubMed ID: 38643673
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.